<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR558.html">Part 558
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 558.618  Tilmicosin.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Type A medicated article containing 90.7 grams (g) per pound tilmicosin as tilmicosin phosphate (200 g per kilogram).</p><p class="depth0"><em>(b)</em> Approvals. See Nos. 000986 and 016592 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Special considerations--(1) Tilmicosin medicated feeds are restricted to use under a veterinary feed directive (VFD). See Sec. 558.6 of this chapter for required label statements and other limitations.</p><p class="depth0"><em>(1)</em> Tilmicosin medicated feeds are restricted to use under a veterinary feed directive (VFD). See Sec. 558.6 of this chapter for required label statements and other limitations.</p><p class="depth0"><em>(2)</em> VFDs for tilmicosin phosphate shall not be refilled.</p><p class="depth0"><em>(3)</em> Labeling of tilmicosin Type B or Type C medicated feeds must bear the following warnings:</p><p class="depth0"><em>(i)</em> Do not allow horses or other equines access to feeds containing tilmicosin.</p><p class="depth0"><em>(ii)</em> [Reserved]</p><p class="depth0"><em>(4)</em> Special considerations for use of tilmicosin medicated swine feeds include the following:</p><p class="depth0"><em>(i)</em> The expiration date of VFDs for tilmicosin must not exceed 90 days from the time of issuance.</p><p class="depth0"><em>(ii)</em> Labeling of tilmicosin Type B or Type C medicated feeds for swine must bear the following warning: ``Do not use in any feeds containing bentonite. Bentonite in feeds may affect the efficacy of tilmicosin.''</p><p class="depth0"><em>(iii)</em> Feed containing tilmicosin shall not be fed to pigs for more than 21 days during each phase of production without ceasing administration for reevaluation of antimicrobial use by a licensed veterinarian before reinitiating a further course of therapy with an appropriate antimicrobial.</p><p class="depth0"><em>(5)</em> Special consideration for use of tilmicosin medicated cattle feeds include the following:</p><p class="depth0"><em>(i)</em> The expiration date of VFDs for cattle must not exceed 45 days from the time of issuance.</p><p class="depth0"><em>(ii)</em> Labeling of tilmicosin Type B or Type C medicated feeds for cattle must bear the following warning: ``Do not use in any feeds containing bentonite, cottonseed meal, or cottonseed hulls. Bentonite, cottonseed meal, or cottonseed hulls in feeds may affect the efficacy of tilmicosin.''</p><p class="depth0"><em>(iii)</em> To assure both food safety and responsible use in cattle, administration of feed containing tilmicosin to cattle experiencing an outbreak of BRD must be initiated during the first 45 days of the production period, shall not exceed a single 14-consecutive-day treatment, should not occur concurrent with or following administration of an injectable macrolide, and should not occur within 3 days following administration of a nonmacrolide injectable BRD therapy. Tilmicosin medicated feed treatment has not been evaluated in cattle with severe clinical disease. Cattle with severe clinical illness should be evaluated for individual treatment with an alternative non-macrolide therapy.</p><p class="depth0"><em>(d)</em> Related tolerances. See Sec. 556.735 of this chapter.</p><p class="depth0"><em>(e)</em> Conditions of use. It is used in feed as follows:</p><p class="depth0"><em>(1)</em> Swine--
----------------------------------------------------------------------------------------------------------------</p><p class="depth0">Tilmicosin phosphate in</p><p class="depth0"><em>(i)</em> 181 to 363.............  ..........................  Swine: For the         Feed continuously as     000986,</p><p class="depth0">control of swine       the sole ration for      016592</p><p class="depth0">respiratory disease    21-day period,</p><p class="depth0">associated with        beginning</p><p class="depth0">Actinobacillus         approximately 7 days</p><p class="depth0">pleuropneumoniae and   before an</p><p class="depth0">Pasteurella            anticipated disease</p><p class="depth0">multocida.             outbreak. The safety</p><p class="depth0">of tilmicosin has</p><p class="depth0">not been established</p><p class="depth0">in male swine</p><p class="depth0">intended for</p><p class="depth0">breeding purposes.</p><p class="depth0">Swine intended for</p><p class="depth0">human consumption</p><p class="depth0">must not be</p><p class="depth0">slaughtered within 7</p><p class="depth0">days of the last</p><p class="depth0">treatment with this</p><p class="depth0">drug product.(ii) [Reserved]............  ..........................  .....................  .....................  .........----------------------------------------------------------------------------------------------------------------</p><p class="depth0"><em>(2)</em> Cattle--</p><p class="depth0">----------------------------------------------------------------------------------------------------------------</p><p class="depth0">Tilmicosin phosphate in</p><p class="depth0"><em>(i)</em> 568 to 757............  ..........................  Beef and nonlactating  Feed continuously for      000986</p><p class="depth0">dairy cattle: For      14 days to provide</p><p class="depth0">the control of         12.5 mg tilmicosin/kg</p><p class="depth0">bovine respiratory     of bodyweight/day.</p><p class="depth0">disease (BRD)          The safety of</p><p class="depth0">associated with        tilmicosin has not</p><p class="depth0">Mannheimia             been established in</p><p class="depth0">haemolytica,           cattle intended for</p><p class="depth0">Pasteurella            breeding purposes.</p><p class="depth0">multocida, and         This drug product is</p><p class="depth0">Histophilus somni in   not approved for use</p><p class="depth0">groups of beef and     in female dairy</p><p class="depth0">nonlactating dairy     cattle 20 months of</p><p class="depth0">cattle, where active   age or older. Use in</p><p class="depth0">BRD has been           these cattle may</p><p class="depth0">diagnosed in at        cause drug residues</p><p class="depth0">least 10 percent of    in milk. This drug</p><p class="depth0">the animals in the     product is not</p><p class="depth0">group.                 approved for use in</p><p class="depth0">calves intended to be</p><p class="depth0">processed for veal. A</p><p class="depth0">withdrawal period has</p><p class="depth0">not been established</p><p class="depth0">in preruminating</p><p class="depth0">calves. Cattle</p><p class="depth0">intended for human</p><p class="depth0">consumption must not</p><p class="depth0">be slaughtered within</p><p class="depth0">28 days of the last</p><p class="depth0">treatment with this</p><p class="depth0">drug product.(ii) 568 to 757...........  Monensin, 5 to 40.........  Cattle fed in          Feed continuously for      000986</p><p class="depth0">confinement for        14 days to provide</p><p class="depth0">slaughter: For         12.5 mg tilmicosin/kg</p><p class="depth0">improved feed          of bodyweight/day.</p><p class="depth0">efficiency; and for    The safety of</p><p class="depth0">the control of         tilmicosin has not</p><p class="depth0">bovine respiratory     been established in</p><p class="depth0">disease (BRD)          cattle intended for</p><p class="depth0">associated with        breeding purposes.</p><p class="depth0">Mannheimia             This drug product is</p><p class="depth0">haemolytica,           not approved for use</p><p class="depth0">Pasteurella            in female dairy</p><p class="depth0">multocida, and         cattle 20 months of</p><p class="depth0">Histophilus somni in   age or older. Use in</p><p class="depth0">groups of cattle fed   these cattle may</p><p class="depth0">in confinement for     cause drug residues</p><p class="depth0">slaughter, where       in milk. This drug</p><p class="depth0">active BRD has been    product is not</p><p class="depth0">diagnosed in at        approved for use in</p><p class="depth0">least 10 percent of    calves intended to be</p><p class="depth0">the animals in the     processed for veal. A</p><p class="depth0">group.                 withdrawal period has</p><p class="depth0">not been established</p><p class="depth0">in pre-ruminating</p><p class="depth0">calves. Cattle</p><p class="depth0">intended for human</p><p class="depth0">consumption must not</p><p class="depth0">be slaughtered within</p><p class="depth0">28 days of the last</p><p class="depth0">treatment with this</p><p class="depth0">drug product. See</p><p class="depth0">Sec. 558.355(d) of</p><p class="depth0">this chapter.(iii) 568 to 757..........  Monensin, 10 to 40........  Cattle fed in          Feed continuously for      000986</p><p class="depth0">confinement for        14 days to provide</p><p class="depth0">slaughter: For         12.5 mg tilmicosin/kg</p><p class="depth0">prevention and         of bodyweight/day.</p><p class="depth0">control of             The safety of</p><p class="depth0">coccidiosis due to     tilmicosin has not</p><p class="depth0">Eimeria bovis and E.   been established in</p><p class="depth0">zuernii; and for the   cattle intended for</p><p class="depth0">control of bovine      breeding purposes.</p><p class="depth0">respiratory disease    This drug product is</p><p class="depth0"><em>(BRD)</em> associated       not approved for use</p><p class="depth0">with Mannheimia        in female dairy</p><p class="depth0">haemolytica,           cattle 20 months of</p><p class="depth0">Pasteurella            age or older. Use in</p><p class="depth0">multocida, and         these cattle may</p><p class="depth0">Histophilus somni in   cause drug residues</p><p class="depth0">groups of cattle fed   in milk. This drug</p><p class="depth0">in confinement for     product is not</p><p class="depth0">slaughter, where       approved for use in</p><p class="depth0">active BRD has been    calves intended to be</p><p class="depth0">diagnosed in at        processed for veal. A</p><p class="depth0">least 10 percent of    withdrawal period has</p><p class="depth0">the animals in the     not been established</p><p class="depth0">group.                 in pre-ruminating</p><p class="depth0">calves. Cattle</p><p class="depth0">intended for human</p><p class="depth0">consumption must not</p><p class="depth0">be slaughtered within</p><p class="depth0">28 days of the last</p><p class="depth0">treatment with this</p><p class="depth0">drug product. See</p><p class="depth0">Sec. 558.355(d) of</p><p class="depth0">this chapter.----------------------------------------------------------------------------------------------------------------

[61 FR 68148, Dec. 27, 1996; 62 FR 15391, Apr. 1, 1997, as amended at 64 FR 13679, Mar. 22, 1999; 65 FR 76930, Dec. 8, 2000; 67 FR 21997, May 2, 2002; 69 FR 78306, Dec. 30, 2004; 76 FR 76894, Dec. 9, 2011; 77 FR 60623, Oct. 4, 2012; 78 FR 19987, Apr. 3, 2013]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
